INITIAL ASSESSMENT OF TUMOR-ASSOCIATED ANTIGEN-CA-125 IN PATIENTS WITH OVARIAN, CERVICAL, AND TESTICULAR-TUMORS

被引:0
|
作者
BUAMAH, PK
CORNELL, C
SKILLEN, AW
CANTWELL, BMJ
HARRIS, AL
机构
[1] FREEMAN HOSP,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE7 7DN,ENGLAND
[2] NEWCASTLE GEN HOSP,DEPT CLIN ONCOL,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND
[3] MED SCH,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE2 4HH,ENGLAND
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:1124 / 1125
页数:2
相关论文
共 50 条
  • [21] A STUDY OF OVARIAN-CANCER PATIENTS USING A RADIOIMMUNOASSAY FOR HUMAN OVARIAN TUMOR-ASSOCIATED ANTIGEN OCA
    KNAUF, S
    URBACH, GI
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 138 (08) : 1222 - 1223
  • [22] Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma
    Picardo, AL
    Diez, M
    Torres, A
    Maestro, M
    Ortega, D
    Hernando, F
    Gomez, A
    GarciaAsenjo, J
    Balibrea, JL
    CANCER, 1996, 77 (06) : 1066 - 1072
  • [23] SIMULTANEOUS DETERMINATION OF CA-125 IN TUMOR CYTOSOL AND IN SERUM IN PATIENTS WITH OVARIAN-TUMORS
    KAESEMANN, H
    CAFFIER, H
    PAULICK, R
    HOFMANN, FJ
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 374 - 375
  • [24] DETECTION OF A NEW TUMOR-ASSOCIATED CARBOHYDRATE ANTIGEN (CA 50) IN THE SERUM OF CARCINOMA PATIENTS
    BRUHN, HD
    JOSS, B
    EULER, HH
    LOFFLER, H
    BLUT, 1985, 51 (03): : 173 - 173
  • [25] Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody
    Chrastina, A
    Pastoreková, S
    Pastorek, J
    NEOPLASMA, 2003, 50 (01) : 13 - 21
  • [26] Tumor-associated antigen c-terminal binding protein-2 is overexpressed in epithelial ovarian tumors
    Barroilhet, Lisa M.
    Yang, Junzheng
    Welch, William R.
    Berkowitz, Ross S.
    Ng, Shu-Wing
    CANCER RESEARCH, 2010, 70
  • [27] RELATIONSHIP OF SERUM CA125 AND LIPID-ASSOCIATED SIALIC-ACID TUMOR-ASSOCIATED ANTIGEN LEVELS TO THE DISEASE STATUS OF PATIENTS WITH GYNECOLOGIC MALIGNANCIES
    STRATTON, JA
    RETTENMAIER, MA
    PHILLIPS, HB
    HERABUTYA, S
    DISAIA, PJ
    OBSTETRICS AND GYNECOLOGY, 1988, 71 (01): : 20 - 26
  • [28] MEASUREMENT OF THE OVARIAN CANCER-ASSOCIATED ANTIGEN CA-125 IN MONITORING TUMOR BURDEN AND RESPONSE TO CHEMOTHERAPY
    QUARANTA, M
    COVIELLO, M
    DONADEO, A
    RELLA, C
    LORUSSO, V
    MICELLI, G
    LUCARELLI, C
    TUMORI JOURNAL, 1991, 77 (02): : 167 - 169
  • [29] STRATEGIES FOR IMPROVING THE SPECIFICITY OF SCREENING FOR OVARIAN-CANCER WITH TUMOR-ASSOCIATED ANTIGENS CA 125, CA 15-3, AND TAG 72.3
    JACOBS, IJ
    ORAM, DH
    BAST, RC
    OBSTETRICS AND GYNECOLOGY, 1992, 80 (03): : 396 - 399
  • [30] EPIDERMAL GROWTH-FACTOR ENHANCES SECRETION OF THE OVARIAN TUMOR-ASSOCIATED CANCER ANTIGEN CA125 FROM THE HUMAN AMNION WISH CELL-LINE
    KONISHI, I
    FENDRICK, JL
    PARMLEY, TH
    QUIRK, JG
    OBRIEN, TJ
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1994, 1 (01) : 89 - 96